STING1 and nasopharyngeal carcinoma: Pharmacological agents (e.g., silybin, fasudil), nanoparticle-based delivery systems, and immunotherapies (e.g., TLR agonists, STING inhibitors) have demonstrated preclinical efficacy in restoring NPC homeostasis.